APA (7th ed.) Citation

Wu, R., Yuan, H., Wang, Y., Gou, X., Hou, W., Zhou, Z., . . . Yan, J. (2025). Norcantharidin inhibits TOP2A expression via H3K27me3 mediated epigenetic regulation to alleviate the progression of hepatocellular carcinoma. Frontiers in Pharmacology, 16, . https://doi.org/10.3389/fphar.2025.1541298

Chicago Style (17th ed.) Citation

Wu, Ruibing, et al. "Norcantharidin Inhibits TOP2A Expression via H3K27me3 Mediated Epigenetic Regulation to Alleviate the Progression of Hepatocellular Carcinoma." Frontiers in Pharmacology 16 (2025). https://doi.org/10.3389/fphar.2025.1541298.

MLA (9th ed.) Citation

Wu, Ruibing, et al. "Norcantharidin Inhibits TOP2A Expression via H3K27me3 Mediated Epigenetic Regulation to Alleviate the Progression of Hepatocellular Carcinoma." Frontiers in Pharmacology, vol. 16, 2025, https://doi.org/10.3389/fphar.2025.1541298.